Nippon Shinyaku Co., Ltd. (NPPNY)
NPPNY Stock Price Chart
Explore Nippon Shinyaku Co., Ltd. interactive price chart. Choose custom timeframes to analyze NPPNY price movements and trends.
NPPNY Company Profile
Discover essential business fundamentals and corporate details for Nippon Shinyaku Co., Ltd. (NPPNY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
16 Nov 2016
Employees
2.21K
CEO
Toru Nakai
Description
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Switzerland, and internationally. The company operates through Pharmaceuticals and Functional Food segments. It offers drugs for urological diseases, inflammation and allergies, hematologic malignancies, cardiovascular and metabolic diseases, gastrointestinal disorders, and other diseases. The company's products include Zalutia for urinary disorder caused by benign prostatic; Eviprostat for prostatic hypertrophy; Bladderon for pollakisuria; Estracyt for prostate cancer; Cialis for erectile dysfunction; Vidaza for myelodysplastic syndrome; Cylocide for solid tumor and acute leukemia; CylocideN for relapsed and refractory acute leukemia and malignant lymphoma; Gazyva for humanized anti-CD20 monoclonal antibody; Defiterio sinusoidal obstruction syndrome; and Trisenox and Amnolake for relapsed and refractory acute promyelocytic leukemia. Nippon Shinyaku Co., Ltd.'s products also comprise Uptravi, Adcirca, and Opsumit for pulmonary arterial hypertension; VILTEPSO for muscular dystrophy; Lunabel LD and Lunabel ULD for dysmenorrhea; Erizas, a dry powder inhaler solution for allergic rhinitis; Azunol Gargle liquid, a gargling solution containing azulene; Isobide for oral osmotic diuresis/meniere's disease; Cephadol for vertigo; Livostin for allergic rhinitis and conjunctivitis; Regtect for maintaining alcohol abstinence; and Onetram and Tramal for cancer and chronic pain. In addition, it researches, develops, and markets drugs in the areas of gynecology, otorhinolaryngology, and orthopedics. Further, the company provides functional foods, such as health food ingredients, preservatives, protein preparations, supplements, and spice and condiments. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
NPPNY Financial Timeline
Browse a chronological timeline of Nippon Shinyaku Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 5 Feb 2026
Upcoming earnings on 11 Nov 2025
Earnings released on 5 Aug 2025
Earnings released on 8 May 2025
Dividend declared on 31 Mar 2025
A dividend of $0.11 per share was announced, adjusted to $0.11. The dividend was paid on 15 Jul 2025.
Earnings released on 7 Feb 2025
Earnings released on 13 Nov 2024
Dividend declared on 30 Sept 2024
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 19 Dec 2024.
Earnings released on 7 Aug 2024
EPS came in at $0.95 , while revenue for the quarter reached $243.63M .
Earnings released on 10 May 2024
EPS came in at $0.18 , while revenue for the quarter reached $234.19M .
Dividend declared on 27 Mar 2024
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 15 Jul 2024.
Earnings released on 9 Feb 2024
EPS came in at $0.74 , while revenue for the quarter reached $242.91M .
Earnings released on 31 Dec 2023
EPS came in at $0.83 , while revenue for the quarter reached $281.74M .
Dividend declared on 28 Sept 2023
A dividend of $0.11 per share was announced, adjusted to $0.11. The dividend was paid on 19 Dec 2023.
Earnings released on 30 Jun 2023
EPS came in at $0.90 , while revenue for the quarter reached $256.10M .
Earnings released on 31 Mar 2023
EPS came in at $0.02 , while revenue for the quarter reached $258.53M .
Dividend declared on 30 Mar 2023
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 17 Jul 2023.
Earnings released on 31 Dec 2022
EPS came in at $0.85 , while revenue for the quarter reached $298.99M .
Earnings released on 30 Sept 2022
EPS came in at $0.72 , while revenue for the quarter reached $245.64M .
Dividend declared on 29 Sept 2022
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 5 Dec 2022.
Earnings released on 30 Jun 2022
EPS came in at $0.90 , while revenue for the quarter reached $262.05M .
Earnings released on 31 Mar 2022
EPS came in at $0.29 , while revenue for the quarter reached $255.69M .
Dividend declared on 29 Mar 2022
A dividend of $0.11 per share was announced, adjusted to $0.11. The dividend was paid on 15 Jul 2022.
Earnings released on 31 Dec 2021
EPS came in at $0.78 , while revenue for the quarter reached $301.25M .
Earnings released on 30 Sept 2021
EPS came in at $0.52 , while revenue for the quarter reached $274.40M .
Dividend declared on 28 Sept 2021
A dividend of $0.11 per share was announced, adjusted to $0.11. The dividend was paid on 17 Dec 2021.
Earnings released on 30 Jun 2021
EPS came in at $1.65 , while revenue for the quarter reached $370.32M .
Earnings released on 31 Mar 2021
EPS came in at $0.75 , while revenue for the quarter reached $271.84M .
Dividend declared on 29 Mar 2021
A dividend of $0.11 per share was announced, adjusted to $0.11. The dividend was paid on 15 Jul 2021.
Earnings released on 31 Dec 2020
EPS came in at $1.01 , while revenue for the quarter reached $329.23M .
Earnings released on 30 Sept 2020
EPS came in at $0.31 , while revenue for the quarter reached $264.34M .
Dividend declared on 28 Sept 2020
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 18 Dec 2020.
NPPNY Stock Performance
Access detailed NPPNY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.